Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

CRBP Corbus Pharmaceuticals

Pre-Mkt 06-30 09:06:13 EDT

8.98

+0.24

+2.75%

盘前8.98

+0.000.00%

09:01 EDT

High9.00	Low8.58	Vol417.79K
Open8.72	D1 Closing8.74	Amplitude4.81%
Mkt Cap166.38M	Tradable Cap121.52M	Total Shares18.53M
T/O3.69M	T/O Rate3.09%	Tradable Shares13.53M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"CRBP","market":"US","secType":"STK","nameCN":"Corbus Pharmaceuticals","latestPrice":8.98,"timestamp":1782763200000,"preClose":8.74,"halted":0,"volume":417785,"hourTrading":{"tag":"盘前","latestPrice":8.98,"preClose":8.98,"latestTime":"09:01 EDT","volume":294,"amount":2643.8999580000004,"timestamp":1782824462234,"change":0,"changeRate":0,"amplitude":0.012249},"delay":0,"changeRate":0.027459954233409634,"floatShares":13532800,"shares":18527795,"eps":-5.660431,"marketStatus":"Pre-Mkt","change":0.24,"latestTime":"06-30 09:06:13 EDT","open":8.72,"high":9,"low":8.58,"amount":3691273.7752549998,"amplitude":0.048055,"askPrice":9.1,"askSize":3000,"bidPrice":8.75,"bidSize":4857,"shortable":3,"etf":0,"ttmEps":-5.660431,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782826200000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":8.98,"preHourTrading":{"tag":"盘前","latestPrice":8.98,"preClose":8.98,"latestTime":"09:01 EDT","volume":294,"amount":2643.8999580000004,"timestamp":1782824462234,"change":0,"changeRate":0,"amplitude":0.012249},"postHourTrading":{"tag":"盘后","latestPrice":9.0481,"preClose":8.98,"latestTime":"19:48 EDT","volume":4490,"amount":40362.5313,"timestamp":1782776901424,"change":0.0681,"changeRate":0.007584,"amplitude":0.007584},"volumeRatio":0.5654516894367442,"optionData":{"bulkOrders":[{"symbol":"CRBP","call":true,"expireDate":1797570000000,"strike":"15.0","timestamp":1782752744269,"price":1.35,"volume":1400,"amount":189000,"type":"+"},{"symbol":"CRBP","call":true,"expireDate":1787284800000,"strike":"10.0","timestamp":1782752744201,"price":1,"volume":1400,"amount":140000,"type":"-"}]},"impliedVol":0.6786,"impliedVolPercentile":0.276},"requestUrl":"/m/hq/s/CRBP","defaultTab":"news","newsList":[{"id":"2647430754","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2647430754","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647430754?lang=en_us&edition=fundamental","pubTime":"2026-06-30 05:21","pubTimestamp":1782768060,"startTime":"0","endTime":"0","summary":"DJ Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 2.75% to $8.98 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 2.07% to 25,820.14 and the Dow Jones Industrial Average  rising 0.59% to 52,182.74.This was the stock's third consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 56.32% below its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 2.16% to $6.14, Fortress Biotech Inc.  rose 6.88% to $2.95, and Viking Therapeutics Inc.  rose 3.94% to $39.54.Trading volume  remained 116,144 below its 50-day average volume of 532,950.Data source: Dow Jones Market D","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646360216","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises 5.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2646360216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646360216?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:35","pubTimestamp":1782506100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. advanced 5.9% to $8.74 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 0.2% to 25,297.62 and Dow Jones Industrial Average falling 0.1% to 51,876.11.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 57.5% short of its 52-week high of $20.56, which the company reached on October 20th.The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 2.7% to $6.01, Fortress Biotech Inc. fell 8.6% to $2.76, and Viking Therapeutics Inc. rose 2.84% to $38.04.Trading volume totaled 2.4 million, compared to the 50-day average of 489,238.Data source: Dow Jones Market Data, FactSet Dow Jones NewswiresJune 26, 2026 16:35 ET Copyright  2026 Dow Jones & Company, Inc.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645854434","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2645854434","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645854434?lang=en_us&edition=fundamental","pubTime":"2026-06-24 05:20","pubTimestamp":1782249600,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 1.81% to $8.46 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 2.21% to 25,587.04 and Dow Jones Industrial Average  falling 0.09% to 51,666.84.This was the stock's fourth consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 58.85% short of its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 0.83% to $5.95, Fortress Biotech Inc.  rose 2.60% to $3.16, and Viking Therapeutics Inc.  rose 7.54% to $34.81.Trading volume  remained 209,006 below its 50-day average volume of 481,916.Data source: Dow Jones Market Data, FactSet. Data compiled June 23, 2026.This content was created by MarketWatch, which is oper","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645565778","title":"Corbus Pharmaceuticals price target lowered to $34 from $44 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2645565778","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645565778?lang=en_us&edition=fundamental","pubTime":"2026-06-24 03:12","pubTimestamp":1782241948,"startTime":"0","endTime":"0","summary":"Mizuho analyst Graig Suvannavejh lowered the firm’s price target on Corbus Pharmaceuticals (CRBP) to $34 from $44 and keeps an Outperform rating on...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/corbus-pharmaceuticals-price-target-lowered-to-34-from-44-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/corbus-pharmaceuticals-price-target-lowered-to-34-from-44-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645267834","title":"Mizuho Securities Cuts Price Target on Corbus Pharmaceuticals to $34 From $44, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2645267834","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645267834?lang=en_us&edition=fundamental","pubTime":"2026-06-23 22:03","pubTimestamp":1782223427,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals (CRBP) has an average rating of buy and mean price target of $36.30, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ma","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MFG","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644316390","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2644316390","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644316390?lang=en_us&edition=fundamental","pubTime":"2026-06-19 05:22","pubTimestamp":1781817720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 2.61% to $8.26 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.91% to 26,517.93 and the Dow Jones Industrial Average  rising 0.14% to 51,564.70.This was the stock's second consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 59.82% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  fell 2.68% to $5.80, Fortress Biotech Inc.  fell 2.61% to $2.99, and Viking Therapeutics Inc.  rose 0.30% to $30.38.Trading volume  remained 180,363 below its 50-day average volume of 478,122.Data source: Dow Jones Market Data, FactSet. Data compiled June 18, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. M","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644031007","title":"Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND) and Corbus Pharmaceuticals (CRBP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2644031007","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644031007?lang=en_us&edition=fundamental","pubTime":"2026-06-18 15:50","pubTimestamp":1781769052,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Ascendis Pharma (ASND) and Corbus Pharmaceuticals (C...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ascendis-pharma-asnd-and-corbus-pharmaceuticals-crbp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4581","LU0109394709.USD","LU0128526141.USD","XBI","BK4588","LU0889565916.HKD","BK4585","LU0320765992.SGD","BK4137","HCSG","XLV","CRBP","ASND","LU0029874061.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644724222","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2644724222","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644724222?lang=en_us&edition=fundamental","pubTime":"2026-06-18 05:19","pubTimestamp":1781731140,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  advanced 2.16% to $8.05 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index  falling 1.34% to 26,021.66 and Dow Jones Industrial Average  falling 0.98% to 51,492.55.Corbus Pharmaceuticals Holdings Inc. closed 60.85% below its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its competitors Wednesday, as Vanda Pharmaceuticals Inc.  rose 4.01% to $5.96, Fortress Biotech Inc.  rose 4.78% to $3.07, and Viking Therapeutics Inc.  rose 2.16% to $30.29.Trading volume  remained 198,629 below its 50-day average volume of 477,586.Data source: Dow Jones Market Data, FactSet. Data compiled June 17, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644595746","title":"Oppenheimer Adjusts PT on Corbus Pharmaceuticals to $52 From $54, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2644595746","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644595746?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:31","pubTimestamp":1781699491,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Holdings (CRBP) has an average rating of buy and mean price target of $36.30, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic researc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRBP","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644746843","title":"Corbus Pharmaceuticals Holdings : Oppenheimer Cuts Target Price to $52 From $54","url":"https://stock-news.laohu8.com/highlight/detail?id=2644746843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644746843?lang=en_us&edition=fundamental","pubTime":"2026-06-17 20:28","pubTimestamp":1781699308,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nAZN4T2T3Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643789341","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises Monday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2643789341","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643789341?lang=en_us&edition=fundamental","pubTime":"2026-06-16 05:20","pubTimestamp":1781558400,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rose 1.59% to $8.32 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 3.07% to 26,683.94 and the Dow Jones Industrial Average  rising 0.92% to 51,671.03.This was the stock's third consecutive day of gains.Corbus Pharmaceuticals Holdings Inc. closed 59.53% short of its 52-week high of $20.56, which the company achieved on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Vanda Pharmaceuticals Inc.  rose 0.17% to $5.88, Fortress Biotech Inc.  rose 3.25% to $2.86, and Viking Therapeutics Inc.  rose 3.06% to $29.63.Trading volume  remained 135,929 below its 50-day average volume of 471,308.Data source: Dow Jones Market Data, FactSet. Data compiled June 15, 2026.This content was created by MarketWatch, which is o","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642329022","title":"Corbus Pharmaceuticals Holdings Inc. Stock Rises Thursday, Still Underperforms Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2642329022","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642329022?lang=en_us&edition=fundamental","pubTime":"2026-06-12 05:22","pubTimestamp":1781212920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 1.04% to $7.78 Thursday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index  rising 2.54% to 25,809.66 and the Dow Jones Industrial Average  rising 1.86% to 50,848.75.Corbus Pharmaceuticals Holdings Inc. closed 62.16% short of its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Vanda Pharmaceuticals Inc.  rose 1.16% to $6.10, Fortress Biotech Inc.  fell 0.36% to $2.76, and Viking Therapeutics Inc.  rose 3.10% to $28.61.Trading volume  remained 105,027 below its 50-day average volume of 463,346.Data source: Dow Jones Market Data, FactSet. Data compiled June 11, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is publ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642394234","title":"Corbus Pharma director Winston Kung reports disposal of 2,026 common shares worth $16,026.85","url":"https://stock-news.laohu8.com/highlight/detail?id=2642394234","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642394234?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:31","pubTimestamp":1781209873,"startTime":"0","endTime":"0","summary":"Sale priced at USD 7.91 per share on a weighted-average basis.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDLfR4Y1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Corbus Pharma director Winston Kung reports disposal of 2,026 common shares worth $16,026.85","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642234317","title":"Corbus Pharma director Anne Altmeyer disposes of 2,412 shares worth $19,085.82","url":"https://stock-news.laohu8.com/highlight/detail?id=2642234317","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642234317?lang=en_us&edition=fundamental","pubTime":"2026-06-12 04:31","pubTimestamp":1781209868,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals director Anne Altmeyer sold 2,412 common shares on June 10, 2026 at a weighted average price of $7.91.Beneficial ownership fell to 7,579 shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL59fSg2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642149074","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2642149074","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642149074?lang=en_us&edition=fundamental","pubTime":"2026-06-10 05:21","pubTimestamp":1781040060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  rallied 1.85% to $7.70 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average  rising 0.17% to 50,872.11 and the NASDAQ Composite Index  falling 0.97% to 25,678.82.Corbus Pharmaceuticals Holdings Inc. closed 62.55% below its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  rose 3.03% to $6.12, Fortress Biotech Inc.  rose 2.81% to $2.93, and Viking Therapeutics Inc.  fell 0.03% to $29.23.Data source: Dow Jones Market Data, FactSet. Data compiled June 9, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641283631","title":"Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641283631","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641283631?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:21","pubTimestamp":1780694460,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 5.62% to $7.56 Friday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index  falling 4.18% to 25,709.43 and Dow Jones Industrial Average  falling 1.35% to 50,866.78.Corbus Pharmaceuticals Holdings Inc. closed 63.23% short of its 52-week high of $20.56, which the company reached on October 20th.The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc.  fell 3.52% to $6.03, Fortress Biotech Inc.  fell 4.33% to $2.65, and Viking Therapeutics Inc.  fell 4.47% to $28.45.Trading volume  remained 132,328 below its 50-day average volume of 459,153.Data source: Dow Jones Market Data, FactSet. Data compiled June 5, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641167854","title":"Corbus Pharmaceuticals Holdings Inc. Stock Climbs 8.5%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2641167854","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641167854?lang=en_us&edition=fundamental","pubTime":"2026-06-05 04:32","pubTimestamp":1780605120,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc. rose 8.5% to $8.01 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 1.7% to 51,561.93 and the NASDAQ Composite Index falling 0.1% to 26,830.96.The stock's rise snapped a three-day losing streak.Corbus Pharmaceuticals Holdings Inc. closed 61.0% below its 52-week high of $20.56, which the company achieved on October 20th.The stock outperformed some of its peers, as Vanda Pharmaceuticals Inc. rose 2.6% to $6.25, Fortress Biotech Inc. rose 6.1% to $2.77, and Viking Therapeutics Inc. rose 1.53% to $29.78.Trading volume totaled 829,309, compared to the 50-day average of 444,970.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640135007","title":"Top Corbus Pharmaceuticals Executive Quietly Makes a Bold Insider Move","url":"https://stock-news.laohu8.com/highlight/detail?id=2640135007","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640135007?lang=en_us&edition=fundamental","pubTime":"2026-06-04 10:10","pubTimestamp":1780539001,"startTime":"0","endTime":"0","summary":"New insider activity at Corbus Pharmaceuticals ( ($CRBP) ) has taken place on June 3, 2026. Corbus Pharmaceuticals just saw a notable insider move ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-corbus-pharmaceuticals-executive-quietly-makes-a-bold-insider-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-corbus-pharmaceuticals-executive-quietly-makes-a-bold-insider-move-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640829281","title":"Corbus Chief Business Officer Nishant Saxena acquires $101,115 of common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2640829281","media":"Reuters","labels":["shareholding","insiderTrades","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640829281?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:37","pubTimestamp":1780522642,"startTime":"0","endTime":"0","summary":"Corbus Pharmaceuticals Chief Business Officer Nishant C. Saxena bought 13,500 common shares in open-market purchases.Saxena’s beneficial ownership rose to 75,300 shares following the transactions.Purchase prices were USD 7.33 per share on a weighted-average basis for part of the buying, rising to USD 7.58 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL5v1TXV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Corbus Chief Business Officer Nishant Saxena acquires $101,115 of common shares","news_tag":"shareholding,insiderTrades,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640192628","title":"Corbus Pharmaceuticals Holdings Inc. Stock Outperforms Competitors Despite Losses On The Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2640192628","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640192628?lang=en_us&edition=fundamental","pubTime":"2026-06-03 05:21","pubTimestamp":1780435260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Corbus Pharmaceuticals Holdings Inc.  shed 2.71% to $7.54 Tuesday, on what proved to be an all-around great trading session for the stock market, with the NASDAQ Composite Index  rising 0.03% to 27,093.90 and the Dow Jones Industrial Average  rising 0.45% to 51,307.79.This was the stock's second consecutive day of losses.Corbus Pharmaceuticals Holdings Inc. closed 63.33% below its 52-week high of $20.56, which the company reached on October 20th.The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc.  fell 3.69% to $6.13, Fortress Biotech Inc.  rose 3.11% to $2.65, and Viking Therapeutics Inc.  fell 6.33% to $29.29.Trading volume  eclipsed its 50-day average volume of 423,548.Data source: Dow Jones Market Data, FactSet. Data compiled June 2, 2026.This content was created by MarketWatch, which is operated by Dow Jon","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRBP"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.corbuspharma.com","stockEarnings":[{"period":"1week","weight":0.0806},{"period":"1month","weight":0.1353},{"period":"3month","weight":-0.0437},{"period":"6month","weight":0.1032},{"period":"1year","weight":0.2135},{"period":"ytd","weight":0.1032}],"compareEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.1394},{"period":"6month","weight":0.0866},{"period":"1year","weight":0.2051},{"period":"ytd","weight":0.0866}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.363358},{"month":2,"riseRate":0.363636,"avgChangeRate":-0.048678},{"month":3,"riseRate":0.636364,"avgChangeRate":0.197993},{"month":4,"riseRate":0.545455,"avgChangeRate":0.046477},{"month":5,"riseRate":0.583333,"avgChangeRate":0.055971},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.048628},{"month":7,"riseRate":0.272727,"avgChangeRate":-0.050382},{"month":8,"riseRate":0.636364,"avgChangeRate":0.095672},{"month":9,"riseRate":0.272727,"avgChangeRate":-0.086452},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.124298},{"month":11,"riseRate":0.727273,"avgChangeRate":0.130055},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.132264}],"exchange":"NASDAQ","name":"Corbus Pharmaceuticals","nameEN":"Corbus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Corbus Pharmaceuticals,CRBP,Corbus Pharmaceuticals股票,Corbus Pharmaceuticals股票老虎,Corbus Pharmaceuticals股票老虎国际,Corbus Pharmaceuticals行情,Corbus Pharmaceuticals股票行情,Corbus Pharmaceuticals股价,Corbus Pharmaceuticals股市,Corbus Pharmaceuticals股票价格,Corbus Pharmaceuticals股票交易,Corbus Pharmaceuticals股票购买,Corbus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Corbus Pharmaceuticals(CRBP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Corbus Pharmaceuticals(CRBP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}